Metrikler
Yayın
12
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (10)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (7)
ESCI (2)
Scopus (6)
TRDizin (7)
2023
20231. Evaluation of upper gastrointestinal system endoscopy screening in patients with acromegaly: a single center experience
EMÜR GÜNAY Y., Durak S., ÜÇÜNCÜ O., COSAR A. M.
Cukurova Medical Journal
, cilt.48, sa.1, ss.145-152, 2023 (ESCI, TRDizin)
2023
20232. The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort
Yaras S., Demir M., Barutcu S., Yildirim A. E., GÜREL S., Ucbilek E., et al.
Hepatology Forum
, cilt.4, sa.3, ss.92-96, 2023 (ESCI, Scopus, TRDizin)
2022
20223. Evaluation of the safety and antiviral efficacy of the tenofovir alafenamide fumarate molecule in immunosuppressed patients
Durak S., Coşar A. M.
JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.5, sa.6, ss.1688-1692, 2022 (TRDizin)
2022
20224. Our experience with percutaneous endoscopic gastrostomy and long-term follow-up results
Durak S., Fidan S., Erkut M., Coşar A. M.
Anatolian Current Medical Journal , cilt.4, sa.4, ss.455-458, 2022 (TRDizin)
2022
20225. Determination of the Frequency of Gastric Intestinal Metaplasia and Its Association with Helicobacter Pylori
DURAK S., COŞAR A. M., FİDAN S.
Medical records-international medical journal (Online)
, cilt.4, sa.3, ss.467-472, 2022 (TRDizin)
2022
20226. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study
GÖKCAN H., YAPALI S., Harputluoglu M., Ellik Z. M. L., Gokcen P., ADANIR H., et al.
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded, Scopus)
2022
20227. Real-Life Data on Sofosbuvir/Ledipasvir in Patients with Chronic Viral Hepatitis C Genotype 1b: A Single-Center Experience
COŞAR A. M., DURAK S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.33, sa.3, ss.240-247, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
20228. Gastrointestinal Bleeding Risk Factors in Patients with Type 2 Diabetes Mellitus
Kisioglu S. V., Habiboglu I., Gunay Y. E., DURAK S., Karakullukcu S., FİDAN S.
Journal of the College of Physicians and Surgeons Pakistan
, cilt.32, sa.1, ss.15-19, 2022 (SCI-Expanded, Scopus)
2021
20219. Risk of hepatitis B reactivation in patients receiving anti-tumor necrosis factor-alpha therapy
FİDAN S., ÇAPKIN E., Arica D., DURAK S., Okatan I. E.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.24, sa.2, ss.254-259, 2021 (SCI-Expanded, Scopus)
2019
201910. Comparison of Clinical and Genetic Characteristics of Familial Mediterranean Fever Patients Among Adult Age Groups
FİDAN S., Seferli S., DURAK S., Seferoglu C. K., OKATAN İ. E., ÇEBİ A. H., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.1, sa.8, 2019 (SCI-Expanded, Scopus, TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2019
20191. Gastrik bezoar ve ananas suyu
COŞAR A. M., DURAK S.
5. Gastrointestinal Endoskopi Günleri, 12 - 13 Nisan 2019, (Özet Bildiri)
Kitaplar
2022
20221. GASTROİNTESTİNAL METAPLAZİNİN YÖNETİMİ VE GÜNCEL ÖNERİLER
Durak S., Coşar A. M.
GASTROİNTESTİNAL SİSTEM HASTALIKLARINDA YENİ NE VAR 2022, MEHMET DEMİR Editör Yardımcıları Prof. Dr. Fatih Albayrak Prof. Dr. Hilmi Ataseven Prof. Dr. Hakan Dursun Doç. Dr. Mehmet Asıl Prof. Dr. Ahmet Uyanıkoğlu Dr. Öğr. Üyesi Arif Mansur Coşar, Editör, US AKADEMİ, İzmir, ss.613-624, 2022